RxDoctor Payments Data

Rachel Chamberlin, PA

Physician Assistant · Hermitage, TNNPI 1952817835

Payments from drug & device makers

$1,973in general payments, 2019–2025

Across 71 payments — averaging $27.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$750
  • Inspire Medical Systems, Inc.$228
  • Regeneron Healthcare Solutions, Inc.$226
  • Alk-abello, Inc$151
  • AstraZeneca$123
  • Optinose US, Inc.$123
  • plus $372 from 8 others

What the payments were for

  • Food & beverage$1,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,973 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$90,015
Medicare patients
470
Services billed
1,972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine60$13,122
Azelastine Hcl333$7,359
Fluticasone Propionate451$7,244
Arnuity ElliptaFluticasone Furoate29$6,589
Ipratropium Bromide126$4,268
SymbicortBudesonide/Formoterol Fumarate16$3,888
Montelukast Sodium137$1,758
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth17$1,668
Cefdinir64$1,495
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,309
Dexamethasone Sodium Phosphate28$1,164
Mometasone Furoate36$920
Ofloxacin38$821
Omeprazole61$715
Fluocinolone Acetonide Oil11$615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAEpinephrine$85$13,12260 claims
GSKArnuity Ellipta$73$6,58929 claims
AstraZenecaSymbicort$123$3,88816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Hermitage

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →